These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 22910137)
1. Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents. Pierce LT; Cahill MM; Winfield HJ; McCarthy FO Eur J Med Chem; 2012 Oct; 56():292-300. PubMed ID: 22910137 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues. Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885 [TBL] [Abstract][Full Text] [Related]
3. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors. Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives. Zhou Y; Xu X; Sun Y; Wang H; Sun H; You Q Bioorg Med Chem Lett; 2013 May; 23(10):2974-8. PubMed ID: 23566520 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives. Ferlin MG; Gia O; Dalla Via L ChemMedChem; 2011 Oct; 6(10):1872-83. PubMed ID: 21826796 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II. Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers. Li PH; Jiang H; Zhang WJ; Li YL; Zhao MC; Zhou W; Zhang LY; Tang YD; Dong CZ; Huang ZS; Chen HX; Du ZY Eur J Med Chem; 2018 Feb; 145():498-510. PubMed ID: 29335211 [TBL] [Abstract][Full Text] [Related]
9. Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors. Kalirajan R; Kulshrestha V; Sankar S; Jubie S Eur J Med Chem; 2012 Oct; 56():217-24. PubMed ID: 22982526 [TBL] [Abstract][Full Text] [Related]
10. A novel tetrahydrobenzoangelicin with dark and photo biological activity. Dalla Via L; Gia O; Caffieri S; García-Argáez AN; Quezada E; Uriarte E Bioorg Med Chem; 2012 Jun; 20(11):3603-8. PubMed ID: 22537681 [TBL] [Abstract][Full Text] [Related]
11. Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs). Wang X; Chen Z; Tong L; Tan S; Zhou W; Peng T; Han K; Ding J; Xie H; Xu Y Eur J Med Chem; 2013 Jul; 65():477-86. PubMed ID: 23770449 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents. Genès C; Lenglet G; Depauw S; Nhili R; Prado S; David-Cordonnier MH; Michel S; Tillequin F; Porée FH Eur J Med Chem; 2011 Jun; 46(6):2117-31. PubMed ID: 21435753 [TBL] [Abstract][Full Text] [Related]
13. N-thioalkylcarbazoles derivatives as new anti-proliferative agents: synthesis, characterisation and molecular mechanism evaluation. Sinicropi MS; Iacopetta D; Rosano C; Randino R; Caruso A; Saturnino C; Muià N; Ceramella J; Puoci F; Rodriquez M; Longo P; Plutino MR J Enzyme Inhib Med Chem; 2018 Dec; 33(1):434-444. PubMed ID: 29383954 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors. My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965 [TBL] [Abstract][Full Text] [Related]
16. Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity. Abdel-Aziz M; Park SE; Abuo-Rahma Gel-D; Sayed MA; Kwon Y Eur J Med Chem; 2013 Nov; 69():427-38. PubMed ID: 24090914 [TBL] [Abstract][Full Text] [Related]
17. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition. Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison. Karki R; Park C; Jun KY; Kadayat TM; Lee ES; Kwon Y Eur J Med Chem; 2015 Jan; 90():360-78. PubMed ID: 25437622 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytostatic evaluation and structure activity relationships of novel bis-indolylmethanes and their corresponding tetrahydroindolocarbazoles. El Sayed MT; Ahmed KM; Mahmoud K; Hilgeroth A Eur J Med Chem; 2015 Jan; 90():845-59. PubMed ID: 25528338 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Thapa U; Thapa P; Karki R; Yun M; Choi JH; Jahng Y; Lee E; Jeon KH; Na Y; Ha EM; Cho WJ; Kwon Y; Lee ES Eur J Med Chem; 2011 Aug; 46(8):3201-9. PubMed ID: 21601964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]